Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics (Q35116171)

6 August 2017

1 reference

title

Oxidative stress in neurodegenerative diseases: therapeutic implications for superoxide dismutase mimetics (English)

1 reference

6 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12718737

28 December 2023

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

28 December 2023

author name string

Kevin Pong

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

full work available at URL

6 August 2017

http://www.tandfonline.com/doi/pdf/10.1517/14712598.3.1.127

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Expert Opinion on Biological Therapy

28 December 2023

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

127-139

1 reference

Extending functional life span

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Mitochondrial DNA repair of oxidative damage in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Oxidative modification of proteins during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Mitochondrial DNA repair and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Delaying brain mitochondrial decay and aging with mitochondrial antioxidants and metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Hydrogen peroxide in the human body.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Antioxidant defence mechanisms: from the beginning to the end (of the beginning).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Superoxide anion radical (O2-.), superoxide dismutases, and related matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Lipid peroxidation in membranes and low-density lipoproteins: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Antioxidants and oxidants regulated signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Cellular glutathione and thiols metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Glutathione catabolism as a signaling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Cell signalling and the glutathione redox system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Aging: a theory based on free radical and radiation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Physiologic effects of lowering caloric intake in nonhuman primates and nonobese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

FLP recombinase-mediated induction of Cu/Zn-superoxide dismutase transgene expression can extend the life span of adult Drosophila melanogaster flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Oxidation of polyamines and brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Methodological considerations and factors affecting 8-hydroxy-2-deoxyguanosine analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

The association between neuronal nitric oxide synthase and neuronal sensitivity in the brain after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

The significance of nitric oxide production in the brain after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Regional vulnerability to endogenous and exogenous oxidative stress in organotypic hippocampal culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Vitamin E and beta-carotene protect against ethanol combined with ischemia in an embryonic rat hippocampal culture model of fetal alcohol syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Inhibition of iron-dependent and ischemia-induced brain damage by the alpha-tocopherol analogue MDL 74,722.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Pharmacologic properties of phenyl N-tert-butylnitrone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Bcl-2 family gene products in cerebral ischemia and traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Ascorbate regulation and its neuroprotective role in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Neuroprotective actions of selegiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Glutathione, iron and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Mitochondrial involvement in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Models of repair mechanisms for future treatment modalities of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Is cell aging caused by respiration-dependent injury to the mitochondrial genome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Mitochondrial genetics: a paradigm for aging and degenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Neuroprotective effects of estrogens: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Manganese superoxide dismutase overexpression attenuates MPTP toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Amyotrophic lateral sclerosis: a proposed mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Six important themes in amyotrophic lateral sclerosis (ALS) research, 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Coenzyme Q10 as a possible treatment for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Effect of creatine supplementation on metabolite levels in ALS motor cortices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Requirement for superoxide in excitotoxic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Dependence of excitotoxic neurodegeneration on mitochondrial aconitase inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Mitochondrial superoxide production in kainate-induced hippocampal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Protein and DNA oxidation in spinal injury: neurofilaments--an oxidation target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Metalloporphyrin class of therapeutic catalytic antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Prevention of 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced nitration of tyrosine hydroxylase and neurotoxicity by EUK-134, a superoxide dismutase and catalase mimetic, in cultured dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Attenuation of staurosporine-induced apoptosis, oxidative stress, and mitochondrial dysfunction by synthetic superoxide dismutase and catalase mimetics, in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Role of polyamine metabolism in kainic acid excitotoxicity in organotypic hippocampal slice cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Attenuation of zinc-induced intracellular dysfunction and neurotoxicity by a synthetic superoxide dismutase/catalase mimetic, in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Pharmacological interventions for stroke: failures and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Antioxidant Profile and Early Outcome in Stroke Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.1.127

Aging: phenomena and theories

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

28 December 2023

Aging: overview.

4

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Calorie restriction enhances the expression of key metabolic enzymes associated with protein renewal during aging

28 December 2023

26

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Human implications of caloric restriction's effects on aging in laboratory animals: an overview of opportunities for research

28 December 2023

27

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Extension of Life-Span with Superoxide Dismutase/Catalase Mimetics

28 December 2023

35

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.

28 December 2023

52

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women

28 December 2023

59

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Understanding cell death in Parkinson's disease

28 December 2023

64

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Oestrogen as a neuroprotective hormone

28 December 2023

72

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice

28 December 2023

73

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats

28 December 2023

74

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN)

28 December 2023

77

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

28 December 2023

84

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2.

28 December 2023

86

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene

28 December 2023

87

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L.

28 December 2023

97

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis

28 December 2023

100

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients

28 December 2023

101

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis

28 December 2023

102

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Benefit of a combined treatment with trientine and ascorbate in familial amyotrophic lateral sclerosis model mice

28 December 2023

105

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis

28 December 2023

106

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Blood oxidative stress in amyotrophic lateral sclerosis

28 December 2023

111

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study

28 December 2023

112

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

28 December 2023

113

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

A mimic of superoxide dismutase activity based upon desferrioxamine B and manganese(IV)

28 December 2023

118

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Salen-manganese complexes are superoxide dismutase-mimics

28 December 2023

119

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Salen-manganese complexes: combined superoxide dismutase/catalase mimics with broad pharmacological efficacy

28 December 2023

120

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced lung injury in vivo

28 December 2023

123

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury

28 December 2023

124

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats

28 December 2023

131

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model

28 December 2023

140

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics.

28 December 2023

141

1 reference

https://api.crossref.org/works/10.1517/14712598.3.1.127

28 December 2023

Identifiers

1 reference

6 August 2017

1 reference